# |
PMID |
Sentence |
1 |
18032587
|
Because SOSTDC1 suppresses proliferation of renal carcinoma cells, restoration of SOSTDC1 signaling may represent a novel target in treatment of renal clear cell carcinoma.
|
2 |
19255250
|
Extracellular antagonists such as connective tissue growth factor (CTGF; CCN-2) and sclerostin domain-containing-1 (SOSTDC1; USAG-1) are important determinants of BMP signaling activity in glomeruli.
|
3 |
19255250
|
BMP signaling activity was visualized by phosphorylated Smad1, -5, and -8 (pSmad1/5/8) immunostaining, and related to expression of CTGF, SOSTDC1, and the podocyte differentiation markers WT1, synaptopodin, and nephrin.
|
4 |
19255250
|
Nephrin and synaptopodin were decreased in diabetic glomeruli.
|
5 |
19255250
|
SOSTDC1 and CTGF were expressed exclusively in podocytes.
|
6 |
19255250
|
In diabetic glomeruli, SOSTDC1 decreased in parallel with podocyte number, whereas CTGF was strongly increased.
|
7 |
19255250
|
This might relate to concomitant overexpression of CTGF but not SOSTDC1.
|
8 |
19255250
|
Extracellular antagonists such as connective tissue growth factor (CTGF; CCN-2) and sclerostin domain-containing-1 (SOSTDC1; USAG-1) are important determinants of BMP signaling activity in glomeruli.
|
9 |
19255250
|
BMP signaling activity was visualized by phosphorylated Smad1, -5, and -8 (pSmad1/5/8) immunostaining, and related to expression of CTGF, SOSTDC1, and the podocyte differentiation markers WT1, synaptopodin, and nephrin.
|
10 |
19255250
|
Nephrin and synaptopodin were decreased in diabetic glomeruli.
|
11 |
19255250
|
SOSTDC1 and CTGF were expressed exclusively in podocytes.
|
12 |
19255250
|
In diabetic glomeruli, SOSTDC1 decreased in parallel with podocyte number, whereas CTGF was strongly increased.
|
13 |
19255250
|
This might relate to concomitant overexpression of CTGF but not SOSTDC1.
|
14 |
19255250
|
Extracellular antagonists such as connective tissue growth factor (CTGF; CCN-2) and sclerostin domain-containing-1 (SOSTDC1; USAG-1) are important determinants of BMP signaling activity in glomeruli.
|
15 |
19255250
|
BMP signaling activity was visualized by phosphorylated Smad1, -5, and -8 (pSmad1/5/8) immunostaining, and related to expression of CTGF, SOSTDC1, and the podocyte differentiation markers WT1, synaptopodin, and nephrin.
|
16 |
19255250
|
Nephrin and synaptopodin were decreased in diabetic glomeruli.
|
17 |
19255250
|
SOSTDC1 and CTGF were expressed exclusively in podocytes.
|
18 |
19255250
|
In diabetic glomeruli, SOSTDC1 decreased in parallel with podocyte number, whereas CTGF was strongly increased.
|
19 |
19255250
|
This might relate to concomitant overexpression of CTGF but not SOSTDC1.
|
20 |
19255250
|
Extracellular antagonists such as connective tissue growth factor (CTGF; CCN-2) and sclerostin domain-containing-1 (SOSTDC1; USAG-1) are important determinants of BMP signaling activity in glomeruli.
|
21 |
19255250
|
BMP signaling activity was visualized by phosphorylated Smad1, -5, and -8 (pSmad1/5/8) immunostaining, and related to expression of CTGF, SOSTDC1, and the podocyte differentiation markers WT1, synaptopodin, and nephrin.
|
22 |
19255250
|
Nephrin and synaptopodin were decreased in diabetic glomeruli.
|
23 |
19255250
|
SOSTDC1 and CTGF were expressed exclusively in podocytes.
|
24 |
19255250
|
In diabetic glomeruli, SOSTDC1 decreased in parallel with podocyte number, whereas CTGF was strongly increased.
|
25 |
19255250
|
This might relate to concomitant overexpression of CTGF but not SOSTDC1.
|
26 |
19255250
|
Extracellular antagonists such as connective tissue growth factor (CTGF; CCN-2) and sclerostin domain-containing-1 (SOSTDC1; USAG-1) are important determinants of BMP signaling activity in glomeruli.
|
27 |
19255250
|
BMP signaling activity was visualized by phosphorylated Smad1, -5, and -8 (pSmad1/5/8) immunostaining, and related to expression of CTGF, SOSTDC1, and the podocyte differentiation markers WT1, synaptopodin, and nephrin.
|
28 |
19255250
|
Nephrin and synaptopodin were decreased in diabetic glomeruli.
|
29 |
19255250
|
SOSTDC1 and CTGF were expressed exclusively in podocytes.
|
30 |
19255250
|
In diabetic glomeruli, SOSTDC1 decreased in parallel with podocyte number, whereas CTGF was strongly increased.
|
31 |
19255250
|
This might relate to concomitant overexpression of CTGF but not SOSTDC1.
|